chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Screamming high pitch cry for 4 days.  After that limp, pale, and seems dazed and out of it.  Stopped smiling, rolling over, just laid there, with no intercation or reaction.  Brought him in to doctor, I think on the 4th or 5th day to see if there was some other reason he was acting this way.  The doctor could not find any infection or cause for his stop in development, lethargy and loss in reaction and interaction.  Just sent me home.  When I went in back in January, the doctor told me that they would never give him another DPT shot, instead they would only give him a DT shot.  He had a reaction to that as well.  Softball size raised hot swollen rash at injection site that covered his whole thigh.  The nurse commented that she was glad she would not have to give him another shot.  It took him several months to get back to smiling and rolling over and interacting.  We spent months interacting with him excessively to get him to come out of this trance like state he was in.
Since the second shot of the vaccine I have been experiencing numbness in my feet and hands like they are falling asleep. Also thought it was weird that everybody complained about getting a little sick after the second shot and with me I did not get any side affects. Of course arm hurt where the shot was but only for a few hours. Other then that no side effects except for the feet  and hand thing which might not even be related to the vaccine. Just thought I would let you know just in case others have had the same thing happen. Thanks
Patient reported headache, nausea, fainting while in shower causing knee injury, fatigue, and body aches. She did not specify how long these symptoms lasted for.
Subsequently post vax, the pt developed myalgia. This is one of many pts from this facility who experienced this event following receipt of vax.
Red itchy rash in chest and abdomen. Slowly expanding to neck and thighs as well.
the pain in my knees, hips joints, my shoulders and my back was almost unbearable; the pain in my knees, hips joints, my shoulders and my back was almost unbearable; Now the pain in my legs is indescribable; This is a spontaneous report from a contactable consumer (patient). A 60-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported), via an unspecified route of administration, administered in left arm on 15Mar2021(age at vaccination was 60 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not have known allergies. The patient did not have covid prior to vaccination. Patient did not receive any other vaccine in four weeks. The patient previously took savella for fibromyalgia and bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in right arm on as dose 1, single for covid-19 immunisation and experienced severe joint pain and very lethargic after a week. On an unspecified date after second vaccination less than a week the patient experienced pain in her knees, hips joints, her shoulders and her back was almost unbearable. Now the pain in her legs was indescribable. Patient was very active until the second vaccination and now she spends her days in bed or sitting with her legs elevated to help with the pain. The patient did not tested for covid post vaccination. It was unknown that patient received treatment or not. The outcome of all the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt recv vax on 4/21/99; 3 hr post vax pt exp sore LA, swollen/hard/ painful upper LA
Information has been received from a physician concerning an approximately 20 week old patient, with no known medical history, who on approximately 19-AUG-2011, was vaccinated with a dose of RECOMBIVAX HB Lot number 0596A is an invalid lot number for RECOMBIVAX HB (route not reported) 0.5ml. Concomitant therapy included PENTACEL. The physician reported that on approximately 19-AUG-2011, the patient experienced a high fever lasting more than 24 hours. The patient did not seek medical attention and was not given any treatment for the event. No laboratory tests were performed. On an unspecified date, the patient was recovered. This is one of several reports received from the same source. Additional information has been requested.
On 8/14 local reaction - red firm area size of egg - Proceeded w/ peripheral redness for 6" around the bump, itchy, hot. Onset in <24 hr - treated with ice, BENADRYL and Sx finally starting to resolve on 8/17
Patient reports that about 12 hours after getting her MMR vaccination she started having pain in her right side over her ribs.  She reports pain that made it difficult for her to sleep the whole night.  She was seen in the ER and found to have an elevated WBC and they performed an X-ray, UA, and an Ultrasound.  They sent her home with Naprosyn when her testing was all normal.  She woke up the next day with swelling of the face and the rib pain being markedly improved.  She was seen in the ER for swelling of the face and there was concern for possible Mumps.  Prior to the vaccination she was totally well.  No exposure to Mumps and no recent travel to high risk areas.  She does work with Cadets (college students) and she reports that she works with make-up and gets exposed to other women on a weekly basis.  No fevers or chills during this illness.  Does not feel ill.
Itch then singular bump then blister then oozed with scratching to left inferior medial knee, right posterior linferor lateral scapula; now scabbing
On  6/20/21, I woke up with a severe bloody nose, running out both my nose and my mouth. I bled profusely for over an hour. Spent time at the ER at 4:30am and then again at a different ER again at 8:00am. Finally got it stopped. I have never had a bloody nose before. Currently, I am still extremely achy.
Patient called,  stating  swelling of arm and lymph nodes within 24 hrs of injection and lump at site.  Applied ice and heat. States it is getting better but if "ball" does not get any better would like to be seen.  Agreed with aptient
This spontaneous report was received from a nurse refers to a 3 month old patient of unknown gender. Patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-JAN-2019, the patient was vaccinated with PNEUMOVAX 23 lot # N030987 (expiry date: 15-MAY-2019) for prophylaxis (product administered to patient of inappropriate age). No adverse events were reported.
Flu shot received 11/3/08. States toward the end of November (approx. Nov 12th) he developed an achiness in both shoulders rating it a #5. States elbows also sensitive. (L) elbow ached first then  (R) elbow. Was going to see an MD, but pain disappeared "98%" so did not seek medical care.
Patient was given a dose of Pfizer that was administered past the 12 hour time frame of the vials first puncture. Per Pfizer there is data to support the stability of the vaccine up to 24 hours if stored in 2-8 Celsius which vaccine was.
Fever 103.8 max. Went to ER, LD, CXR normal
Left arm. 8x11 cm redness, swelling, itching. Treated with Clindamycin HCL 300mg take every 8 hours x 10 days.
pt recv vax 17JUL96 4PM & later pt told mom the inj hurt all the way to the hand;tx w/ice & ibuprofen for 3wk;seen by MD 8AUG96 & 15AUG96 & still c/o pain in upper arm & lt shoulder;pain cont of & on as of 26AUG96;
MISADMINISTRATION - 4yo series given at age 3 - no adverse events noticed
neck felt "thick" almost like swollen lymph node. mild tickle/cough. no shortness of breath or difficulty swallowing.
mild/partial loss of smell; headache; sinus discomfort (pressure, ache); Chest tightness/achiness; Chest tightness/achiness; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL-9261/expiration date: not provided), via intramuscular route of administration, on 30Jan2021 at 09:00 (at the age of 48 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history was reported as none. The patient did not have any known allergies. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included vitamin D, cetirizine hydrochloride (ALLERTEC), and paracetamol (TYLENOL) (a few times after vaccine due to symptoms).  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Feb2021 (also reported as "02Jan2021"), the patient experienced chest tightness/achiness. On 03Feb2021, (also reported as "03Jan2021"), the patient experienced mild/partial loss of smell, headache, and sinus discomfort (pressure, ache). The events required an emergency room visit/physician office visit. The patient did not receive any treatment for these events. The patient was assessed by ER on 02Feb2021: EKG, chest X-RAY and bloodwork looked good. It was assumed COVID due to recent exposure, however, 72 hour COVID test nasal swab PCR on 03Feb2021 and rapid test SARS Antigen FIA on 06Feb were negative. The patient had a post vaccination nasal swab, covid test name unsure - NOT rapid, covid test result pending. The outcome of the events chest tightness/achiness, mild/partial loss of smell, headache, and sinus discomfort (pressure, ache) was not recovered.
Irregular menstrual cycle since second dose of vaccine. I have not had a regular period since then. It is now 5/25/2021. I only had light spotting in April 2021. NOT pregnant. I have taken multiple pregnancy tests.
The second dose of Pfizer was taken on April 21, 2 and a half weeks after the first, not on the same day. I've been dealing with a SUBSTANTIAL increase in the number of hypoglycemic episodes I endure on any given day since my vaccination. I've been a diagnosed type 1 diabetic since December, 2016. Prior to April of 2021, I had never suffered from a hypoglycemic seizure. Since April, I have had several. This past November I even had 2 in the same weekend.  Upon observing my blood sugar levels carefully with a CGM (Continuous Glucose Monitor), it appears what has changed is that while before if my blood sugar was low (i.e. 60-70), they would stabilize and would rarely drop below assuming I didn't overdose on insulin. But now, my blood sugar levels will continuously drop with seemingly no ending point (I can't confirm, as if below 40, I will either start a seizure requiring myself to haphazardly feed myself sugar, or have someone do it for me). I have seen instances of my blood sugar being above 200 2 hours after a meal,  deciding not to eat for several hours and watching it drop to 45. This would have never happened before April.  My insulin doses did not increase shortly before my symptoms began. Glucagon is the hormone that raises blood sugar during a low - I speculate that, somehow, the vaccine has interfered with the ability of glucagon to stimulate glucose production in my liver.  I also seem to get a moderate reprieve from my symptoms when I have a cold. This has happened several times, my blood sugar patterns will return to normal temporarily. Before April I was in the low range 8% of the time, according to my CGM. Now I'm northwards of 20%. I've almost had seizures with no one around before, which would have been life threatening.
The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022; The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A, 008C21A and 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 02-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Date the vial was initially stored in the refrigerator on 11-Jan-2022. The vial did not undergo any temperature excursions. No patient has reported adverse reaction. No treatment medications were reported
T102.6, h/a, lethargic, no appetite, very weak lasted 24hr no signs of any other illness;
Site: Pain at Injection Site-Mild, Systemic: nausea-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: patient recieved vaccine, shortly after she wasn't feeling well.  patient was tended to promptly,  pulse taken and determined to be alert and temperature was taken.  patient was watched after not feeling well and then left after  mother checked out and said she was fine and a followup phone call was given to patient mother at 350 pm to see how child was doing and she said she was find
FAINTED; This spontaneous report received from a patient via a company representative concerned a 19 year old male of an unknown ethnicity and race. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: Unknown) dose was not reported, 1 total administered on 06-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On the same day, the patient fainted (syncope) after vaccination. The patient woke up later and did not had to go to the hospital, however someone had to drive patient home. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fainted on 06-MAY-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210535593-COVID-19 VACCINE AD26.COV2.S-fainted. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt called 1/31 and said left side numb and in pain, went to MD and he said muscle spasm ok and call if gets worse.
fever (103F); chills; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever (103F)), CHILLS (chills) and MYALGIA (muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever (103F)), CHILLS (chills) and MYALGIA (muscle pain). At the time of the report, PYREXIA (fever (103F)), CHILLS (chills) and MYALGIA (muscle pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 103 f (High) 103 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.    This case was linked to MOD-2021-025595, MOD-2021-072130 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-025595:Wife's first dose MOD-2021-072130:Wife's second dose
Information has been received from a health professional concerning an 8 year old male with no medical history or allergies who on an unspecified date was vaccinated with a first dose of VARIVAX. Subsequently the patient experienced an anaphylactic reaction. On 17-AUG-2007, at 8 years of age the patient was vaccinated SC on upper left extremity with a 0.5 ml second dose of VARIVAX (Lot # 658062/0829U). There was no concomitant medication. There was no illness at the time of vaccination. On 17-AUG-2007 the patient had an anaphylactic reaction after vaccination. The patient vomited and his face turned blue. The patient was treated with oxygen, epinephrine and BENADRYL. The patient's body was covered with itchy rash. It was reported that the patient was treated in the office and ambulance was not called. No diagnostic laboratory test was undertaken. At the time of report the patient was recovering. A product quality complaint was not involved. A lot check has been initiated. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. The patient's experiences were considered to be an other important medical event and life threatening by the reporter. Additional information has been received from the medical assistant who stated that on 17-AUG-2007 the patient developed an itchy rash then the patient's lips turned blue. The patient was given oxygen and epinephrine injection. The patient was put on oxygen for 1 hour. The patient was also given BENADRYL. The patient recovered on the same date.
Tested positive for covid after getting first dose; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CORONAVIRUS TEST POSITIVE (Tested positive for covid after getting first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CORONAVIRUS TEST POSITIVE (Tested positive for covid after getting first dose). At the time of the report, CORONAVIRUS TEST POSITIVE (Tested positive for covid after getting first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Coronavirus test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up information received on 10-MAY-2021 contains no significant information. On 10-May-2021: Follow-up information received on 10-MAY-2021 contains no significant information.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Initial information received from a healthcare professional on 21 September 2012. A 50-year-old female patient with no reported illness at the time of vaccination and with infrequent slight twinge in both wrists had received a dose of FLUZONE (batch number unknown) intramuscularly on left deltoid on 18 September 2012. On 19 September 2012 i.e. 01 day after vaccination, the patient experienced left wrist and hand weakness and pain which got worse on 20 September 2012. The patient got slight relief using heating pad. It was reported that on 21 September 2012 the patient was improving and may see the physician for follow-up. Laboratory details were not reported. As of 21 September 2012, the patient had not recovered from the events. Follow-up information was received from a healthcare professional on 05 December 2012. Based upon the new information this case has been upgraded to serious. The lot number for FLUZONE was UH756AA. The patient was seen by an orthopedist and diagnosed with distal ulnar joint degeneration. Symptoms resolved on 28 September 2012. The diagnosis was determined by the orthopedist to not be related to the vaccine. The patient had no illness at the time of vaccination and received no other vaccines within four weeks of FLUZONE. Past medical history included hypothyroid, hypertension (HTN) and diabetes. Concomitant medications included SYNTHROID, metformin, atenolol and lisinopril. The patient received yearly influenza vaccines. Outcome was recovered. Documents held by sender: None.
I had several days of bad episodes at night - that kept me up - of abdominal pain. Was unable to sleep. Nexium OTC for treatment. That helped with symptoms. I had those about 5 days. I saw my doctor on Friday. I am still having a little bit of symptoms but not like it was.
Suspected vaccination failure; had a bad case of shingles and I had already had the shot.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The patient self reported the case. The age at vaccination was not reported. The patient had a bad case of shingles and he/she had already had the shot. The patent said it did not work for him/her. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
Patient passed out after recieving vaccine. Patient experienced sweating.  Onsite EMS was called vitals HR 57 BP 89/41 BG 63. He was given some water & chocolate.  He recovered with BP 112/59 and  passenger drove home.
Adverse event   Allergic reactions a rash with swelling on my torso, face, arms, chest and stomach.  other side effects were headache, muscle pain, low grade fever and tiredness.